What Happened?
A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.
For healthcare providers and medical device manufacturers, lower oil prices directly reduce the cost of operating large hospital facilities and shipping sensitive medical equipment. This margin relief is vital for a sector that has been squeezed by high transportation overhead, allowing for a more favorable outlook on quarterly earnings. The "risk-on" sentiment sparked by the ceasefire is also driving capital back into high-growth biotech and pharmaceutical names.
As broader market volatility recedes, investors are more willing to fund long-term R&D and clinical trials that were previously shadowed by macroeconomic uncertainty. The stabilization of the global economy ensures that both elective procedures and pharmaceutical demand remain on a steady upward trajectory for the remainder of 2026.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Research Tools & Consumables company Revvity (NYSE: RVTY) jumped 4.4%. Is now the time to buy Revvity? Access our full analysis report here, it’s free.
- Research Tools & Consumables company Bio-Techne (NASDAQ: TECH) jumped 3.3%. Is now the time to buy Bio-Techne? Access our full analysis report here, it’s free.
- Branded Pharmaceuticals company Corcept (NASDAQ: CORT) jumped 4.9%. Is now the time to buy Corcept? Access our full analysis report here, it’s free.
- Branded Pharmaceuticals company Supernus Pharmaceuticals (NASDAQ: SUPN) jumped 4.1%. Is now the time to buy Supernus Pharmaceuticals? Access our full analysis report here, it’s free.
- Branded Pharmaceuticals company Phibro Animal Health (NASDAQ: PAHC) jumped 5.3%. Is now the time to buy Phibro Animal Health? Access our full analysis report here, it’s free.
Zooming In On Phibro Animal Health (PAHC)
Phibro Animal Health’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was about 1 month ago when the stock gained 3.7% on the news that easing crude oil prices helped lift investor sentiment and reduce inflation worries.
The retreat in oil prices provided temporary relief to a market that was volatile amid geopolitical tensions. Lower energy costs can help temper inflation, which had been a primary concern for the economy and corporate profits.
As a result, major indices like the S&P 500 and Dow Jones Industrial Average saw significant gains. This positive macroeconomic development boosted investor confidence across most sectors, leading to widespread buying activity that included major stocks within the healthcare industry, which rose in tandem with the overall market.
Phibro Animal Health is up 53.1% since the beginning of the year, and at $57.10 per share, it is trading close to its 52-week high of $59.58 from April 2026. Investors who bought $1,000 worth of Phibro Animal Health’s shares 5 years ago would now be looking at an investment worth $2,281.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
